Literature DB >> 28808858

Vitamin D and Heart Failure.

D Marshall Brinkley1, Omair M Ali1, Sandip K Zalawadiya1, Thomas J Wang2.   

Abstract

PURPOSE: Vitamin D is principally known for its role in calcium homeostasis, but preclinical studies implicate multiple pathways through which vitamin D may affect cardiovascular function and influence risk for heart failure. Many adults with cardiovascular disease have low vitamin D status, making it a potential therapeutic target. We review the rationale and potential role of vitamin D supplementation in the prevention and treatment of chronic heart failure. RECENT
FINDINGS: Substantial observational evidence has associated low vitamin D status with the risk of heart failure, ventricular remodeling, and clinical outcomes in heart failure, including mortality. However, trials assessing the influence of vitamin D supplementation on surrogate markers and clinical outcomes in heart failure have generally been small and inconclusive. There are insufficient data to recommend routine assessment or supplementation of vitamin D for the prevention or treatment of chronic heart failure. Prospective trials powered for clinical outcomes are warranted.

Entities:  

Keywords:  Cardiovascular disease; Heart failure; Outcomes; Vitamin D

Mesh:

Substances:

Year:  2017        PMID: 28808858     DOI: 10.1007/s11897-017-0355-7

Source DB:  PubMed          Journal:  Curr Heart Fail Rep        ISSN: 1546-9530


  82 in total

1.  Clinical and laboratory safety of one year's use of a combination calcium + vitamin D tablet in ambulatory elderly women with vitamin D insufficiency: results of a multicenter, randomized, double-blind, placebo-controlled study.

Authors:  Michel Brazier; Franck Grados; Saïd Kamel; Marc Mathieu; Alain Morel; Mohamed Maamer; Jean-Luc Sebert; Patrice Fardellone
Journal:  Clin Ther       Date:  2005-12       Impact factor: 3.393

Review 2.  Vitamin D deficiency.

Authors:  Michael F Holick
Journal:  N Engl J Med       Date:  2007-07-19       Impact factor: 91.245

3.  Latitude and ischaemic heart disease.

Authors:  A Fleck
Journal:  Lancet       Date:  1989-03-18       Impact factor: 79.321

4.  Cardiomyocyte-specific deletion of the vitamin D receptor gene results in cardiac hypertrophy.

Authors:  Songcang Chen; Christopher S Law; Christopher L Grigsby; Keith Olsen; Ting-Ting Hong; Yan Zhang; Yerem Yeghiazarians; David G Gardner
Journal:  Circulation       Date:  2011-09-26       Impact factor: 29.690

5.  Vitamin D therapy in individuals with prehypertension or hypertension: the DAYLIGHT trial.

Authors:  Pankaj Arora; Yanna Song; Jeffery Dusek; Gregory Plotnikoff; Marc S Sabatine; Susan Cheng; Andre Valcour; Heather Swales; Beth Taylor; Erin Carney; Derek Guanaga; Joseph R Young; Courtney Karol; Michael Torre; Atum Azzahir; Semerit M Strachan; Dillon C O'Neill; Myles Wolf; Frank Harrell; Christopher Newton-Cheh; Thomas J Wang
Journal:  Circulation       Date:  2014-10-30       Impact factor: 29.690

6.  Vitamin D status and the risk of cardiovascular disease death.

Authors:  Annamari Kilkkinen; Paul Knekt; Antti Aro; Harri Rissanen; Jukka Marniemi; Markku Heliövaara; Olli Impivaara; Antti Reunanen
Journal:  Am J Epidemiol       Date:  2009-09-17       Impact factor: 4.897

7.  Short-term vitamin D3 supplementation lowers plasma renin activity in patients with stable chronic heart failure: an open-label, blinded end point, randomized prospective trial (VitD-CHF trial).

Authors:  Nicolas F Schroten; Willem P T Ruifrok; Lennaert Kleijn; Martin M Dokter; Herman H Silljé; Hiddo J Lambers Heerspink; Stephan J L Bakker; Ido P Kema; Wiek H van Gilst; Dirk J van Veldhuisen; Hans L Hillege; Rudolf A de Boer
Journal:  Am Heart J       Date:  2013-06-24       Impact factor: 4.749

Review 8.  Vitamin D and Cardiovascular Disease.

Authors:  Thomas J Wang
Journal:  Annu Rev Med       Date:  2016       Impact factor: 13.739

9.  Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease.

Authors:  Orlando M Gutiérrez; James L Januzzi; Tamara Isakova; Karen Laliberte; Kelsey Smith; Gina Collerone; Ammar Sarwar; Udo Hoffmann; Erin Coglianese; Robert Christenson; Thomas J Wang; Christopher deFilippi; Myles Wolf
Journal:  Circulation       Date:  2009-05-04       Impact factor: 29.690

10.  Vitamin D inhibits monocyte/macrophage proinflammatory cytokine production by targeting MAPK phosphatase-1.

Authors:  Yong Zhang; Donald Y M Leung; Brittany N Richers; Yusen Liu; Linda K Remigio; David W Riches; Elena Goleva
Journal:  J Immunol       Date:  2012-02-01       Impact factor: 5.422

View more
  3 in total

Review 1.  Vitamin D Supplementation Guidelines for General Population and Groups at Risk of Vitamin D Deficiency in Poland-Recommendations of the Polish Society of Pediatric Endocrinology and Diabetes and the Expert Panel With Participation of National Specialist Consultants and Representatives of Scientific Societies-2018 Update.

Authors:  Agnieszka Rusińska; Paweł Płudowski; Mieczysław Walczak; Maria K Borszewska-Kornacka; Artur Bossowski; Danuta Chlebna-Sokół; Justyna Czech-Kowalska; Anna Dobrzańska; Edward Franek; Ewa Helwich; Teresa Jackowska; Maria A Kalina; Jerzy Konstantynowicz; Janusz Książyk; Andrzej Lewiński; Jacek Łukaszkiewicz; Ewa Marcinowska-Suchowierska; Artur Mazur; Izabela Michałus; Jarosław Peregud-Pogorzelski; Hanna Romanowska; Marek Ruchała; Piotr Socha; Mieczysław Szalecki; Mirosław Wielgoś; Danuta Zwolińska; Arkadiusz Zygmunt
Journal:  Front Endocrinol (Lausanne)       Date:  2018-05-31       Impact factor: 5.555

2.  Identification of patients at risk of new onset heart failure: Utilizing a large statewide health information exchange to train and validate a risk prediction model.

Authors:  Son Q Duong; Le Zheng; Minjie Xia; Bo Jin; Modi Liu; Zhen Li; Shiying Hao; Shaun T Alfreds; Karl G Sylvester; Eric Widen; Jeffery J Teuteberg; Doff B McElhinney; Xuefeng B Ling
Journal:  PLoS One       Date:  2021-12-10       Impact factor: 3.240

3.  The effect of the comorbidity burden on vitamin D levels in geriatric hip fracture.

Authors:  Ing How Moo; Carmen Jia Wen Kam; Eric Wei Liang Cher; Bryan Ce Jie Peh; Chung Ean Lo; David Thai Chong Chua; Ngai Nung Lo; Tet Sen Howe; Joyce Suang Bee Koh
Journal:  BMC Musculoskelet Disord       Date:  2020-08-08       Impact factor: 2.362

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.